(Q50723601)
Statements
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction. (English)
1 reference
P Devroey
1 reference
M Ludwig
1 reference
R E Felberbaum
1 reference
C Albano
1 reference
H Riethmüller-Winzen
1 reference
A Schüler
1 reference
W Engel
1 reference
K Diedrich
1 reference
1 July 2000
1 reference
264
1 reference
1
1 reference
29-32
1 reference